CIK 0001781983
- Non-accelerated filer
- Smaller reporting company
Aprea Therapeutics, Inc.
Sign in to watch- Ticker
- APRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 215-948-4119
- Business address
- 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-31 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Purchase · Pre-Funded Warrant | +30,978 | $0.81 | $25K | 30,978 |
| 2026-03-31 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Purchase · Common Warrant | +30,978 | 30,978 | ||
| 2026-03-12 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Grant or award | +10,095 | 43,528 | ||
| 2026-03-12 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Grant or award · Stock Options (Right to Buy) | +40,380 | 40,380 | ||
| 2026-01-30 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Purchase | +5,700 | $0.89 | $5K | 33,433 |
| 2026-01-30 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Purchase · Common Warrant | +5,700 | 5,700 | ||
| 2025-12-10 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Purchase | +5,000 | $1.17 | $6K | 27,733 |
| 2025-12-10 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Purchase · Common Warrant | +5,000 | 5,000 | ||
| 2025-03-27 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Grant or award | +3,365 | 22,733 | ||
| 2025-03-27 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Grant or award · Stock Options (Right to Buy) | +13,460 | 13,460 | ||
| 2024-10-11 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Purchase | +50 | $2.46 | $123 | 19,368 |
| 2024-10-10 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Purchase | +450 | $2.61 | $1K | 19,318 |
| 2024-03-28 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Grant or award | +3,365 | 18,868 | ||
| 2024-03-28 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Grant or award · Stock Options (Right to Buy) | +13,460 | 13,460 | ||
| 2024-03-13 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Purchase | +1,010 | $7.29 | $7K | 15,503 |
| 2024-03-13 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Purchase · Tranche A Warrant | +505 | 505 | ||
| 2024-03-13 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Purchase · Tranche B Warrant | +505 | 505 | ||
| 2023-02-27 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Grant or award | +1,000 | $5.25 | $5K | 14,493 |
| 2023-01-30 | Hamill John P. SrVP/CFO/Prin. Fin&Acctg. Off | Grant or award | +269,879 | 269,879 | ||
| 2023-01-30 | Hamill John P. SrVP/CFO/Prin. Fin&Acctg. Off | Grant or award · Employee Stock Option (Right to Buy) | +539,758 | 539,758 |
Page 1 of 1 · 20 trades